The UK government is initiating trials of weight-loss jabs for unemployed people to help them re-enter the workforce, backed by a £279 million investment from Eli Lilly.
NHS Chief Executive Amanda Pritchard highlighted the lifesaving potential of weight-loss drugs, which could substantially lower health risks associated with obesity, aiding public health and economic productivity.
Health Secretary Wes Streeting stated that the trials could significantly impact unemployment rates and reduce strain on the NHS, underlining the life-changing potential of these medications.
Obesity is identified as a major preventable cause of various health issues, with the UK government believing that weight-loss jabs can facilitate better work participation and improved health outcomes.
Collection
[
|
...
]